• Comparison of Blood Culture Contamination Rates
Comparison of Blood Culture Contamination Rates Between the Use of Povidine Iodine/Alcohol for Skin Antisepsis and the Use of Chlorhexidine/Alcohol (ChloraPrep) for Skin Antisepsis: An Open-label, Randomized Controlled Trial
1 other identifier
interventional
500
0 countries
N/A
Brief Summary
In this study, blood culture contamination rates will be compared in patients who used povidine/iodine-alcohol and chlorhexidine/alcohol, which were applied before the blood culture was taken by randomized two methods routinely used in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedStudy Start
First participant enrolled
October 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFebruary 1, 2023
January 1, 2023
1 year
October 9, 2022
January 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Contamination
The primary endpoint of the study was to reduce the rate of contamination in blood cultures.
14 days
Study Arms (2)
1.The culture taken after disinfection with providing/iodine
ACTIVE COMPARATOR1.Blood cultures routinely performed with alcohol/povidine-iodine
2.The culture taken after disinfection with chlorhexidine/alcohol
ACTIVE COMPARATOR2\. Blood cultures routinely performed with chlorhexidine/alcohol
Interventions
lood cultures can be routinely performed with alcohol/povidine-iodine or alcohol/chlorhexidine. The topical disinfectants used in the two applications are the topical disinfectants included in the guidelines and currently applied in our hospital.
Eligibility Criteria
You may qualify if:
- patients who will be hospitalized at SBU Izmir Dr. Patients who are hospitalized in the Pediatric Infection Service of Behçet Uz Pediatrics and Surgery Training and Research Hospital, and who will require blood culture indications will participate in the study If they are willing to
You may not qualify if:
- The patents with central lines will be excluded.
- The patient who were transferred from ICU's will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor. Dr.
Study Record Dates
First Submitted
October 9, 2022
First Posted
October 12, 2022
Study Start
October 15, 2023
Primary Completion
November 1, 2024
Study Completion
December 1, 2024
Last Updated
February 1, 2023
Record last verified: 2023-01